The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates - PubMed (original) (raw)

Review

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates

Koichi Wakabayashi et al. Neuropathology. 2007 Oct.

Abstract

The histological hallmark of Parkinson's disease (PD) is the presence of fibrillar aggregates called Lewy bodies (LBs). LB formation has been considered to be a marker for neuronal degeneration, because neuronal loss is found in the predilection sites for LBs. To date, more than 70 molecules have been identified in LBs, in which alpha-synuclein is a major constituent of LB fibrils. Alpha-synuclein immunohistochemistry reveals that diffuse cytoplasmic staining develops into pale bodies via compaction, and that LBs arise from the peripheral portion of pale bodies. This alpha-synuclein abnormality is found in 10% of pigmented neurons in the substantia nigra and more than 50% of those in the locus ceruleus in PD. Recent studies have suggested that oligomers and protofibrils of alpha-synuclein are cytotoxic, and that LBs may represent a cytoprotective mechanism in PD.

PubMed Disclaimer

Cited by

Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
Schulz-Schaeffer WJ. Schulz-Schaeffer WJ. Biomolecules. 2015 Jul 16;5(3):1467-79. doi: 10.3390/biom5031467. Biomolecules. 2015. PMID: 26193328 Free PMC article. Review.
Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.
Hatton SL, Pandey MK. Hatton SL, et al. Int J Mol Sci. 2022 Jan 19;23(3):1089. doi: 10.3390/ijms23031089. Int J Mol Sci. 2022. PMID: 35163013 Free PMC article. Review.
Cellular and Molecular Events Leading to Paraquat-Induced Apoptosis: Mechanistic Insights into Parkinson's Disease Pathophysiology.
See WZC, Naidu R, Tang KS. See WZC, et al. Mol Neurobiol. 2022 Jun;59(6):3353-3369. doi: 10.1007/s12035-022-02799-2. Epub 2022 Mar 19. Mol Neurobiol. 2022. PMID: 35306641 Free PMC article. Review.
Dementia with Lewy bodies - from scientific knowledge to clinical insights.
Arnaoutoglou NA, O'Brien JT, Underwood BR. Arnaoutoglou NA, et al. Nat Rev Neurol. 2019 Feb;15(2):103-112. doi: 10.1038/s41582-018-0107-7. Nat Rev Neurol. 2019. PMID: 30559465 Review.
Differential Expression Profiles and Functional Prediction of Circular RNAs and Long Non-coding RNAs in the Hippocampus of Nrf2-Knockout Mice.
Zhang RJ, Li Y, Liu Q, Gao YJ, Du J, Ma J, Sun SG, Wang L. Zhang RJ, et al. Front Mol Neurosci. 2019 Aug 9;12:196. doi: 10.3389/fnmol.2019.00196. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31447646 Free PMC article.

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates - PubMed (original) (raw)